Every two years, the Access to Medicine Index evaluates 20 of the world's leading pharmaceutical companies according to their efforts to address access to medicine for people living in low-middle-income countries (LMICs), where access gaps are the greatest. By ranking companies on their performance on priority access-to-medicine topics across three Technical Areas: Governance of Access, Research & Development (R&D), and Product Delivery, the Index aims to identify Best Practices, track progress, and highlight where critical action is needed to address shortcomings. In this ninth iteration of the Index, Novartis ranks as the top company for the first time, followed closely by GSK, which has previously been in first position across all Index reports.
How do the companies compare in 2024?
Novartis and GSK stand out as the two leaders: Novartis (1st) and GSK (2nd) rank within the top three performers across all three Technical Areas, with Novartis leading in Governance of Access and Research & Development (R&D). The company has robust governance structures in place and demonstrates how it puts policy into practice. For example, Novartis implements a process to measure patient reach (as assessed in Governance of Access) and demonstrates an increase in the number of patients reached through access strategies for its products assessed by the Index within Product Delivery. In addition, Novartis performs well in R&D access planning for both communicable and non-communicable diseases (NCDs), where it has robust plans in place, with broader country coverage compared to peers. GSK demonstrates strong performance across the board, leading in Product Delivery, with a particularly strong performance in access strategies and licensing. It continues to have the largest priority pipeline in comparison to peers, with R&D access plans in place for most pipeline candidates.
Bu hikaye Express Pharma dergisinin December 2024 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Giriş Yap
Bu hikaye Express Pharma dergisinin December 2024 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Giriş Yap
Blissfill-Calibrated syringe pipettes for repetitive laboratory dosing as per ISO 8655-9
Blissfill syringe pipettes provide laboratories with an ergonomic, self-refilling solution for repetitive dosing, delivering precise volumes from 0.05ml to 10ml. With ISO 8655-9 compliance and an included calibration certificate, Blissfill ensures accuracy and ease of use for high-demand lab applications
Ensuring pharma compliance with testo data measurement technology
Comprehensive data measurement tools address regulatory demands and secure quality in pharma
Waters launches software for lab-centric business intelligence enabling audit readiness
waters_connect Data Intelligence software provides laboratories with comprehensive business intelligence on their chromatographic data throughout the product development lifecycle, enabling real-time audit readiness and query response, while reducing time spent on audit preparation
Ensuring clean room integrity with Prime Clean Reset High-Speed Doors
Designed with precision to meet the stringent requirements of controlled environments, Prime Clean Reset is the epitome of performance and reliability, ensuring that your clean room operations consistently meet the highest standards of regulatory compliance and product integrity
Optimising efficiency with Remote Laboratory Solutions
LabWare's comprehensive suite of software solutions designed specifically for laboratories offers reliable Remote Laboratory Solutions to help your business thrive in the current climate
Ensuring water quality with the 6000TOCi: The ultimate solution for continuous TOC measurement
The 6000TOCi Sensor is a comprehensive solution that brings together continuous monitoring, rapid response, reliability, and compliance
Enhancing pharmaceutical analysis in critical areas
Dheeraj Handique, Manager GC/GCMS Product Marketing, Shimadzu Analytical (India) highlights the benefits of GCMS-TQ8050 NX with HS-20 NX trap for genotoxic impurities, nitrosamines, and, extractables and leachables
Technical innovations for Annex 1
To meet the stringent EU GMP Annex 1 requirements, Optima presents innovative solutions to improve product and patient safety in pharmaceutical manufacturing. From minimising glove interventions and optimising First Air flow to advanced automation for integrity testing, this article explores how Optima's technologies support compliance in aseptic fill-and-finish processes
JRS Pharma - The Global MCC Manufacturing Network
JRS Pharma is one of the largest manufacturers of MCC across the globe. The know-how is based on more than 25 years of experience in development of own processes
Mack Pharmatech is the first to launch PLC-based environmental chambers in India
Manoj Choudhari, Managing Director, Mack Pharmatech shares insights on his company's pioneering expand globally and enhance regulatory compliance